Evaluation of the Tolerability of Switching Subjects on Chronic ATC Opioid Therapy to Buprenorphine HCl Buccal Film

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
The primary aim of this study is to determine if chronic pain subjects on around-the-clock opioids who are receiving 100 to 220 mg oral morphine sulfate equivalent (MSE) can be safely transitioned on to buprenorphine hydrochloride (HCl) buccal film at 50% of their MSE dose without inducing opioid withdrawal or reversing analgesic effects.
Epistemonikos ID: 772d729bf71c066c8e7d30f949e1c03eee3af0e7
First added on: May 11, 2024